FDA Panel Rejects Medtronic's New Blood Pressure Device 🚫
Independent FDA experts have expressed doubts about the effectiveness of Medtronic's latest blood pressure treatment device, voting against its approval. Learn more about the implications for patients and the company's future plans.
Benzinga
4 views • Aug 24, 2023
About this video
The FDA's independent experts have delivered a stark verdict on the effectiveness of Medtronic's new blood pressure treatment device. The panel voted against recommending approval of the device due to concerns over its efficacy while voting in favor of a rival device made by ReCor. In clinical trials, Medtronic's device was found to lower blood pressure but not as effectively as that of Otsuka Holdings.
Video Information
Views
4
Duration
0:27
Published
Aug 24, 2023
Related Trending Topics
LIVE TRENDSRelated trending topics. Click any trend to explore more videos.
Trending Now